Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Oberg
L Vrang

Showing results (1-10 of 212) with videos related to

Pageof 22
Sort By:
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 1, 1990
Screening for new agentsB Oberg, L Vrang
Antimicrobial Agents and Chemotherapy|May 1, 1986
PPi analogs as inhibitors of human T-lymphotropic virus type III reverse transcriptaseL Vrang, B Oberg
Antimicrobial Agents and Chemotherapy|November 1, 1988
Reverse transcriptases from human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus (SIVMAC) are susceptible to inhibition by foscarnet and 3'-azido-3'-deoxythymidine triphosphateL Vrang, B Oberg, J Löwer, et al.
Acta Chemica Scandinavica. Series B: Organic Chemistry and Biochemistry|September 1, 1986
The cordycepin analogue of 2,5A and its threo isomer. Chemical synthesis, conformation and biological activityA Nyilas, L Vrang, A Drake, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1987
Different patterns of inhibition of avian myeloblastosis virus reverse transcriptase activity by 3'-azido-3'-deoxythymidine 5'-triphosphate and its threo isomerB Eriksson, L Vrang, H Bazin, et al.
AIDS Research and Human Retroviruses|April 3, 2001
Anti-HIV type 1 activity of 3'-fluoro-3'-deoxythymidine for several different multidrug-resistant mutantsE Y Kim, L Vrang, B Oberg, et al.
Antiviral Research|March 1, 1987
Inhibition of the reverse transcriptase from HIV by 3'-azido-3'-deoxythymidine triphosphate and its threo analogueL Vrang, H Bazin, G Remaud, et al.
Antiviral Research|May 1, 1994
Enzymatic properties and sensitivity to inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase with Glu-138-->Arg and Tyr-188-->His mutationsH Zhang, L Vrang, K Bäckbro, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1989
Inhibition of human immunodeficiency virus in vitro by combinations of 3'-azido-3'-deoxythymidine and foscarnetR Koshida, L Vrang, G Gilljam, et al.
Antiviral Research|December 1, 1995
Inhibition of human immunodeficiency virus type 1 wild-type and mutant reverse transcriptases by the phenyl ethyl thiazolyl thiourea derivatives trovirdine and MSC-127H Zhang, L Vrang, K Bäckbro, et al.
Pageof 22

Showing results (1-10 of 212) with videos related to

Sort By:
Pageof 22
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 1, 1990
Screening for new agentsB Oberg, L Vrang
Antimicrobial Agents and Chemotherapy|May 1, 1986
PPi analogs as inhibitors of human T-lymphotropic virus type III reverse transcriptaseL Vrang, B Oberg
Antimicrobial Agents and Chemotherapy|November 1, 1988
Reverse transcriptases from human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus (SIVMAC) are susceptible to inhibition by foscarnet and 3'-azido-3'-deoxythymidine triphosphateL Vrang, B Oberg, J Löwer, et al.
Acta Chemica Scandinavica. Series B: Organic Chemistry and Biochemistry|September 1, 1986
The cordycepin analogue of 2,5A and its threo isomer. Chemical synthesis, conformation and biological activityA Nyilas, L Vrang, A Drake, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1987
Different patterns of inhibition of avian myeloblastosis virus reverse transcriptase activity by 3'-azido-3'-deoxythymidine 5'-triphosphate and its threo isomerB Eriksson, L Vrang, H Bazin, et al.
AIDS Research and Human Retroviruses|April 3, 2001
Anti-HIV type 1 activity of 3'-fluoro-3'-deoxythymidine for several different multidrug-resistant mutantsE Y Kim, L Vrang, B Oberg, et al.
Antiviral Research|March 1, 1987
Inhibition of the reverse transcriptase from HIV by 3'-azido-3'-deoxythymidine triphosphate and its threo analogueL Vrang, H Bazin, G Remaud, et al.
Antiviral Research|May 1, 1994
Enzymatic properties and sensitivity to inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase with Glu-138-->Arg and Tyr-188-->His mutationsH Zhang, L Vrang, K Bäckbro, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1989
Inhibition of human immunodeficiency virus in vitro by combinations of 3'-azido-3'-deoxythymidine and foscarnetR Koshida, L Vrang, G Gilljam, et al.
Antiviral Research|December 1, 1995
Inhibition of human immunodeficiency virus type 1 wild-type and mutant reverse transcriptases by the phenyl ethyl thiazolyl thiourea derivatives trovirdine and MSC-127H Zhang, L Vrang, K Bäckbro, et al.
Pageof 22